Halozyme wins court order to block Merck's injected Keytruda in select European markets
A Dutch patent court ruled in favor of Halozyme against Merck, ordering the halt of injectable Keytruda sales in eight European markets due to infringement on Halozyme's MDASE delivery technology. Thi
reuters · 2026-10-07 06:29